Difference between revisions of "WSI23-10-Case-1"

From MGH Learn Pathology
Line 64: Line 64:
 
|subject=Z0FBQUFBQmozUk5JRktJcVphVTdqS2xKQ0NNOERCS1lmUHR4WU9yMlR1ZGZLZ1BXV0ZIMm5hdkt4ZkxObjBoSUdUaXVwZlc4X01MZnVBQXVQLWxHS3pzNnJveHZYSEhhSEE9PQ
 
|subject=Z0FBQUFBQmozUk5JRktJcVphVTdqS2xKQ0NNOERCS1lmUHR4WU9yMlR1ZGZLZ1BXV0ZIMm5hdkt4ZkxObjBoSUdUaXVwZlc4X01MZnVBQXVQLWxHS3pzNnJveHZYSEhhSEE9PQ
 
|reasonCode=CD34
 
|reasonCode=CD34
|view=show
+
|view=hide
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}

Revision as of 13:16, February 7, 2023

WSI23-10-Case-1
56 year-old man with history of MDS, now with dropping blood counts. WBC 4.94 (63% polys, 32% lymphs, 1% atypical lymphs, 4% monos, 0% blasts), HGB 7.3, MCV 89, PLT 60.
MDS with excess blasts-1 bordering on pure erythroid leukemia (MDS/AML with mutated TP53/bi-allelic TP53 inactivation).
April 6, 2023 12:00:00 AM